{"filings":[{"id":1553277,"accession_number":"0001104659-26-082254","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2026-07-09T20:05:24+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"XWELL agrees to sell XpresSpa and XpresTest for $13M, pivots to national security","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price of $13M, subject to customary adjustments; $2.65M placed in escrow.","Transaction requires stockholder approval; expected to close later in 2026.","XWELL will retain health and wellness retail outside airports; proceeds to fund growth in national security.","Termination fees: Buyer pays up to $1.3M plus expenses; XWELL pays up to $1.3M plus expenses under certain conditions.","Support agreements from board, executives, and American Ventures LLC to vote in favor; Series H Preferred to convert before record date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92689,"accession_number":"0001104659-26-042125","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K/A","filed_at":"2026-04-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"XWELL board adopts annual Say-on-Pay votes following stockholder preference","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board determined on April 9, 2026, to hold Say-on-Pay votes every year after stockholders expressed preference for annual frequency at Dec. 18, 2025 meeting.","Next advisory vote on frequency of Say-on-Pay votes will occur at 2031 Annual Meeting unless presented earlier.","This amendment to Form 8-K adds disclosure required by Item 5.07(d) regarding board's frequency decision."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92690,"accession_number":"0001104659-26-038550","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2026-04-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL reports FY 2025 revenue of $29.2M, net loss $17.0M; $31.3M private placement in Feb 2026","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $29.2M: XpresSpa $18.6M, XpresCheck $8.3M, Naples Wax Center $2.3M.","Operating loss $15.7M vs $16.7M prior year; net loss attributable to XWELL $17.0M vs $16.9M.","Cost of sales down 13% YoY; G&A down 20%; total operating expenses down 10%.","Opened new wellness location at NYC Penn Station in Dec 2025; expanded in Florida.","Feb 2026 private placement raised ~$31.3M; funds to repurchase notes and redeem Series G Preferred."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103721,"accession_number":"0001104659-26-023569","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","9.01"],"status":"ready","headline":"XWELL closes $31.3M private placement of Series H preferred and warrants; repurchases $9M notes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate gross proceeds of $31,333,000 from issuance of 31,333 Series H convertible preferred (conversion price $0.47) and warrants to purchase 66,665,957 common shares (exercise price $0.345).","Placement agent Dominari Securities received warrants to purchase up to 5,333,277 common shares with same terms.","Used $9M of proceeds to repurchase outstanding Notes and redeem all Series G preferred stock and Series Warrants from prior investors.","Filed Certificate of Elimination for Series G preferred (none outstanding) and Certificate of Designations for Series H preferred.","Private Placement closed in two tranches on Feb 27 and Mar 3, 2026; relied on Section 4(a)(2)/Reg D exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103720,"accession_number":"0001104659-26-019431","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["1.01","3.02","5.02","5.03","8.01","9.01"],"status":"ready","headline":"XWELL raises ~$31.3M via Series H convertible preferred and warrants; repurchases $9M of existing securities","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$31.3M from sale of 31,333 Series H convertible preferred shares (convertible at $0.47/sh) and 66.7M warrants (exercise $0.345/sh, 3yr).","Uses $9M of proceeds to repurchase $5.96M notes, redeem all Series G preferred, and redeem 8.8M warrants from institutional investors.","Remaining proceeds for general corporate purposes and working capital.","Board grants 100,000 shares restricted stock to each of five directors (500,000 total), vesting 30 days after closing.","Dominari Securities LLC acted as exclusive placement agent; receives 8% fee and warrants for 8% of shares underlying securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119985,"accession_number":"0001104659-25-122574","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"XWELL shareholders approve reverse split, share issuance; reject board classification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proposal 6 passed: authorizes reverse stock split at ratio 1:2 to 1:20, at Board's discretion within one year.","Proposal 7 passed: permits issuance of shares >19.99% of outstanding under Exchange Agreement for Series G preferred, warrants, notes.","Proposal 5 failed: board classification into two classes with staggered terms rejected (For: 1,789,561, Against: 721,530).","All five director nominees (Ezra Ernst, Bruce Bernstein, Robert Weinstein, Gaëlle Wizenberg, Michael Lebowitz) reelected with majority support.","Advisory say-on-pay approved with ~78% of votes cast; future frequency set at every three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119984,"accession_number":"0001104659-25-118877","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-12-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"XWELL receives Nasdaq bid price deficiency notice; cure period through June 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Closing bid price below $1.00 for 30 consecutive business days ended Nov 28, 2025.","Compliance period of 180 days, ending June 1, 2026, to regain $1.00 minimum bid.","Must maintain $1.00 closing bid for 10 consecutive days to cure deficiency.","If not cured, may qualify for additional 180 days by meeting other listing standards.","No immediate impact on trading; stock continues on Nasdaq during cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119983,"accession_number":"0001104659-25-112604","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL reports Q3 2025 revenue of $7.3M, net loss narrows to $0.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.3M in Q3 2025; net loss attributable to XWELL $0.7M vs $4.8M in Q3 2024.","Cost of sales down 8%; G&A expenses down 32% from prior-year quarter.","Priority Pass partnership expanded to international airports in Middle East and Europe.","Opened off-airport wellness centers in Brandon, FL and Orlando, FL; Penn Station location set for mid-November.","After Q3, streamlined cost structure, reducing approx $2.4M in annualized staffing costs."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":22056000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119982,"accession_number":"0001104659-25-112475","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"XWELL exchanges $1.55M Series G Preferred for $3.39M convertible notes; amends terms","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged $1,553,806 Stated Value of Series G Preferred Stock (including accrued dividends) for $3,387,138.80 senior secured convertible notes.","Filed Certificate of Amendment reducing Series G conversion price to $1.00 and removing requirement to maintain 200% cash reserves for conversion shares.","Added anti-dilution price-based adjustments to conversion price and provisions for accelerated conversion at lower of installment price or 80% VWAP.","Closing occurred November 10, 2025; exchange intended to modify rights of Series G Preferred holders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119981,"accession_number":"0001104659-25-108548","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"XWELL sets 2025 annual meeting for Dec 18; shareholder proposal deadline Nov 17","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting date moved by more than 30 days from prior year; meeting set for Dec 18, 2025 at 10:00 am ET.","Shareholder proposals under Rule 14a-8 must be received by Nov 17, 2025.","Director nominations and other business outside Rule 14a-8 due Nov 17, 2025.","Universal proxy rule compliance notice also required by Nov 17, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119980,"accession_number":"0001104659-25-106407","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["1.01","2.03","3.02","3.03","5.03","9.01"],"status":"ready","headline":"XWELL exchanges $1.55M Series G Preferred for $3.39M secured notes; warrants amended","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged $1,553,806 aggregate Stated Value of Series G Preferred Stock for $3,387,138.80 senior secured convertible notes.","Notes bear 8% interest, mature in 3 years 4 months, convertible at $1.00/share; quarterly installments start Apr 1, 2026.","Warrants exercise price reduced from $1.496/$1.7952 to $1.00; anti-dilution provisions added.","Certificate of Amendment removes cash covenant, reduces Series G conversion price to $1.00, adds anti-dilution.","Company must hold stockholder meeting by Dec 31, 2025 to approve share issuances exceeding 19.99% limit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119979,"accession_number":"0001104659-25-098042","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"XWELL cancels 2025 annual meeting, withdraws proxy proposals; to reschedule later","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting originally set for Sept 16, 2025, was adjourned to Oct 10, 2025.","Company cancels meeting and withdraws all proposals from Aug 8 proxy statement.","New meeting will be rescheduled; a new proxy statement will be filed with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136554,"accession_number":"0001104659-25-090545","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-09-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"XWELL adjourns 2025 annual meeting to Oct 10, 2025 for more voting time","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual Meeting opened and adjourned on Sept 16, 2025 without conducting any business.","Reconvened virtually on Oct 10, 2025 at 10:00 a.m. ET at www.virtualshareholdermeeting.com/NAOV2025SM2.","Record date remains July 25, 2025; new proxy deadline is 11:59 p.m. ET on Oct 9, 2025.","All previously submitted proxies remain valid; shareholders do not need to revote unless changing their vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136553,"accession_number":"0001104659-25-078661","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q2 2025 revenue $7.7M, net loss $2.3M widens YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.7M, down from $9.3M YoY; sequential improvement from Q1 2025's $7.0M.","Operating loss $2.7M vs $1.9M YoY; net loss $2.3M vs $2.0M YoY.","Cash and equivalents $5.3M; marketable securities $2.9M; no long-term debt.","Named official wellness spa of Orlando Magic; expanded Priority Pass partnership.","CDC biosurveillance contract extended three years through March 2025 renewal."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":14712000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136552,"accession_number":"0001104659-25-075185","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"XWELL regains Nasdaq minimum bid price compliance; delisting risk removed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter confirming compliance with Listing Rule 5550(a)(2) as bid price closed at or above $1.00 for 16 consecutive days.","Compliance period measured from July 16, 2025 to August 6, 2025; matter now closed.","Previously notified of non-compliance on May 13, 2025; this resolution eliminates potential delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136551,"accession_number":"0001104659-25-070824","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"XWELL amends bylaws to lower stockholder vote threshold to majority of votes cast (excluding abstentions)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved First Amendment to Third Amended and Restated Bylaws on July 24, 2025, effective same date.","For matters other than director elections, vote threshold changed from majority of voting power of shares present to majority of votes cast (excluding abstentions and broker non-votes).","Similar change applies to class votes where separate vote is required.","Directors continue to be elected by plurality of votes cast; no change to director election standard."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153742,"accession_number":"0001104659-25-051002","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q1 revenue falls to $7.0M; net loss $4.7M; CDC contract extended 3 years","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.0M, down 19% from $8.7M YoY; net loss attributable $4.7M vs $2.5M.","Cost of sales down 6% to $5.7M; operating expenses down 11% to $4.5M; operating loss $3.2M.","Closed $4M private placement (Series G preferred + warrants) in Jan 2025; cash $3.7M, marketable securities $7.3M, no debt.","Secured 3-year extension of CDC Traveler-based Genomic Surveillance Program (TGS) in March 2025.","Plans to acquire medical spas in Orlando, Dallas, Salt Lake City; new XWELL location at NYC Penn Station mid-2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":7023000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153741,"accession_number":"0001104659-25-050498","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"XWELL (XWEL) receives Nasdaq minimum bid price deficiency notice; cure period to Nov 10, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified XWELL on May 13, 2025 that its common stock's closing bid price was below $1.00 for 30 consecutive business days (Mar 31 - May 12, 2025).","Company has 180 calendar days, until November 10, 2025, to regain compliance by maintaining a $1.00 closing bid for at least ten consecutive business days.","If not compliant by Nov 10, XWELL may qualify for an additional 180-day period if it meets all other Nasdaq Capital Market initial listing standards.","There can be no assurance of eligibility for an additional cure period or that Nasdaq will grant continued listing if delisting proceedings begin.","The notice has no immediate impact on listing; XWELL's common stock continues to trade on Nasdaq pending compliance with other requirements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153740,"accession_number":"0001104659-25-036830","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-04-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"XWELL dismisses Marcum, engages CBIZ CPAs; cites material weaknesses","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Dismissed Marcum LLP and engaged CBIZ CPAs as auditor for FY2025, effective April 21, 2025.","Marcum's reports for FY2024 and FY2023 were unqualified except for going-concern qualification in FY2024.","Disclosed material weaknesses in internal controls: lease accounting, entity-level monitoring, IT vendor controls, revenue process, foreign subsidiaries.","No disagreements or reportable events (other than material weaknesses) between Company and Marcum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153739,"accession_number":"0001104659-25-035179","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-04-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL reports FY 2024 revenue $33.9M (+13% YoY), net loss narrows to $16.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $33.9M (+13% YoY); gross margin rose to 26.3% from 12.2%.","Net loss attributable to XWELL narrowed to $16.9M from $27.7M in 2023.","CDC extended Traveler-based Genomic Surveillance Program for 3 years; base value $53.7M, ceiling $85.7M.","Closed $4M private placement in Jan 2025; plans to acquire medical spas in select metros in 2025.","Cash & equivalents $4.6M, marketable securities $7.3M, no long-term debt."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":7023000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153738,"accession_number":"0001104659-25-034194","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"XWELL stockholders OK share issuance for Series G financing, boost equity plan to 3.125M; classified board fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Share issuance for Jan 2025 Series G Preferred and warrant financing approved (For: 1,329,306; Against: 328,079) to comply with Nasdaq listing rule.","Classified board amendment rejected (For: 1,287,324; Against: 530,101); board remains annually elected.","Equity incentive plan shares increased by 2.5M to total 3.125M shares; non-employee director annual award limit raised to $750,000.","Ratification of CBIZ CPAs P.C. as fiscal 2025 auditor approved (For: 2,918,213)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172422,"accession_number":"0001104659-25-023236","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"XWELL plans medical spa acquisitions; $4M private placement to fund expansion by year-end 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan to acquire select medical spas by end of 2025, leveraging a $4M private placement.","Initial focus on metropolitan areas: Orlando, Austin, and Salt Lake City.","Services will include injectables, body sculpting, laser therapies, and weight loss management.","CEO Ezra Ernst positions this as a move to create a nationwide brand for holistic self-care.","Global med spa market cited as rapidly growing; XWELL aims to blend luxury with medical expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172421,"accession_number":"0001104659-25-020597","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"XWELL announces three-year CDC contract extension for Traveler-based Genomic Surveillance through 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CDC extends Traveler-based Genomic Surveillance Program contract with XWELL for three additional years through 2027.","Contract renewal continues partnership between XWELL and CDC; financial terms not disclosed.","Announcement made on March 5, 2025 via press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172420,"accession_number":"0001104659-25-003620","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","8.01","9.01"],"status":"ready","headline":"XWELL closes $4M private placement of Series G convertible preferred stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raised $4.0M gross proceeds via sale of 4,000 shares of Series G Convertible Preferred Stock (conversion price $1.496) and warrants to investors.","Warrants: Series A at $1.496/share, Series B at $1.7952/share, both exercisable immediately for 5 years.","Proceeds to be used for working capital, AI-driven health/wellness product development, and expansion of XWELL locations beyond airports.","Must file resale registration statement within 30 days and seek stockholder approval for conversion/exercise exceeding 19.99% of outstanding common stock.","Preferred stock carries 8% annual dividend (15% upon trigger event) and mandatory redemption in 6 quarterly installments starting Feb 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172419,"accession_number":"0001104659-25-001576","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2025-01-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"XWELL appoints Ian Brown as CFO effective Jan 6, 2025; Scrabis resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Suzanne Scrabis resigns effective Jan 8, 2025; severance $11,538 bi-weekly for 6 months plus COBRA.","Ian Brown appointed CFO effective Jan 6; base salary $375K, signing bonus $75K, guaranteed bonus $75K, options for 37k shares.","Peter Vermeulen appointed head of HR and Mike Heronime as Marketing Director, both on fractional basis.","Brown has 25+ years in operational finance; previously Managing Director at Accordion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189418,"accession_number":"0001104659-24-125715","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"XWELL CEO outlines 2025 strategy: unify brands under XWELL, open 7 Florida locations by year-end","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan to rebrand airport spa locations worldwide under XWELL identity starting 2025.","Commitment to open seven new out-of-airport retail wellness centers in Florida by end of 2025.","Integrating loyalty programs like Priority Pass and expanding branded wellness products.","Leveraging autonomous services such as robotic manicures and massage chairs to optimize efficiency.","XpresCheck and HyperPointe brands to evolve under XWELL umbrella; XpresCheck continues CDC collaboration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189417,"accession_number":"0001104659-24-119056","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q3 2024 revenue $8.4M (+13% YoY); operating loss narrows to $4.8M from $12.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $8.4M for Q3 2024, up 13% from $7.5M in Q3 2023; YTD revenue up 16%.","Operating loss improved to $4.8M vs $12.1M loss in Q3 2023; total operating expenses fell 48% to $6.8M.","Net loss attributable to XWELL was $4.8M, compared to $11.5M loss in the prior-year quarter.","Cash and marketable securities totaled $16.1M; no long-term debt as of Sept. 30, 2024.","Company plans ~10 out-of-airport locations in 2025 and a Penn Station XpresSpa; August 2024 direct offering raised $1.4M gross."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":26430000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205924,"accession_number":"0001104659-24-102031","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-09-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"XWELL stockholders elect four directors, ratify auditor and tax plan at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four director nominees elected: Bruce T. Bernstein, Robert Weinstein, Gaëlle Wizenberg, Michael Lebowitz.","Marcum LLP ratified as independent auditor for FY 2024 with 2,588,500 votes in favor.","Advisory vote on executive compensation approved with 1,440,521 for, 478,335 against.","Tax Benefits Preservation Plan ratified with 1,762,495 for, 153,660 against.","Former CEO Scott R. Milford resigned from board effective Sept. 21, 2024; his nomination withdrawn."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205923,"accession_number":"0001104659-24-097147","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"XWELL appoints Ezra Ernst as CEO; Scott Milford resigns, to serve as consultant through year-end","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Milford stepped down as President and CEO effective Sept 4, 2024; will serve as consultant at $31,250/month through Dec 31, 2024, plus $425k severance.","Ezra Ernst appointed President and CEO effective Sept 4, 2024; to join Board on Sept 21, 2024.","Ernst receives $425k base salary, annual bonus up to 100% of base (50/50 cash/RSUs), 30k stock options at $1.86/share, and 30k restricted shares vesting over 3 years.","Ernst previously led XpresCheck and HyperPointe; developed CDC traveler-based genomic surveillance program.","Press release cites strategic leadership change to drive growth, innovation, and return to profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205922,"accession_number":"0001104659-24-090328","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-08-16T23:59:59+00:00","items":["1.01","3.03","5.03","8.01","9.01"],"status":"ready","headline":"XWELL adopts poison pill to protect ~$67.3M in net operating loss tax attributes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board declared dividend of one preferred stock purchase right per common share, payable Aug 26, 2024.","Rights trigger if a person/group acquires 4.99%+ of common stock without board approval, causing dilution.","Rights expire Aug 16, 2027, or earlier if tax attributes are utilized or plan is no longer needed.","Plan is intended to prevent a change of ownership under Section 382 that would limit NOL carryforwards.","Existing holders of 4.99%+ are exempt unless they acquire additional shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205921,"accession_number":"0001104659-24-089684","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q2 2024 revenue up 14% to $9.3M; net loss narrows to $2.0M from $5.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $9.3M (vs $8.2M Q2 2023); operating loss improved to $1.9M from $4.7M.","Net loss attributable to XWELL was $2.0M, down from $5.7M in prior year quarter.","Opened new XpresSpa at Philadelphia airport; plans NYC Penn Station later 2024.","CDC issued new 3-year biosurveillance RFP; XpresTest bidding; contract value similar to prior.","Closed $1.4M registered direct offering at $2.18/share; cash & marketable securities $18.4M, no debt."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":18008000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205920,"accession_number":"0001104659-24-086582","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"XWELL raises $1.4M in registered direct offering at $2.18/share premium; issues 416K settlement shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Registered direct offering of 652,705 shares at $2.18/share, gross proceeds ~$1.4M; expected close Aug 8, 2024.","Proceeds from offering will be used for working capital and general corporate purposes.","Issued 416,000 unregistered shares on Aug 5, 2024 as settlement consideration to Settlor Parties (XpresSpa Middle East B.V. and others).","Offering price represents a premium to market, signaling demand.","Shares offered under effective shelf registration statement (Form S-3) filed Aug 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205919,"accession_number":"0001104659-24-081538","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"XWELL says CPC nomination notice invalid; calls for updated 13D filing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CPC Pain & Wellness SPV, formed by Caydan Capital, owns 9.42% stake and nominated four board candidates.","Company alleges CPC's notice lacks required details under bylaws and its 13D is deficient.","CPC filed litigation against XWELL; company plans to dispute vigorously.","XWELL claims CPC seeks control for a 'Take-Under' deal undervaluing the company and diluting stockholders.","Stockholders not required to take any action at this time, XWELL says."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222943,"accession_number":"0001104659-24-063832","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"XWELL adopts amended bylaws with advance notice provisions for stockholder proposals and nominations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Added advance notice requirements for stockholder proposals and director nominations at annual meetings.","For 2024 annual meeting, notice must be received between May 24 and June 23, 2024.","Added process for stockholders to request record date for action by written consent.","Bylaws updated to comply with Rule 14a-9 under the Exchange Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222942,"accession_number":"0001104659-24-061978","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q1 revenue up 24% to $8.7M; operating loss narrows 62% to $2.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $8.7M vs $7.1M YoY; XpresSpa/Treat $4.4M, XpresTest $3.6M, Naples Wax $0.6M.","Operating loss improved 62% to $2.4M; net loss $2.5M vs $5.5M.","Cash $4.3M, marketable securities $14.8M; no long-term debt.","CDC TGS program expanded to Miami/Chicago; estimated funding increased to $36.7M.","Plans to open 3 new Naples Wax Centers in 2024 and XpresSpa at NYC Penn Station this summer."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.6,"consensus_revenue_estimate":null,"consensus_revenue_actual":8726000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222941,"accession_number":"0001104659-24-047806","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-04-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL reports FY2023 revenue drop to $30.1M, net loss $28.0M; restates Q3 2023 results","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2023 total revenue $30.1M (down 46% from $55.9M in 2022); operating loss $28.2M, net loss $28.0M.","Non-cash impairment charges of $8.9M; restated Q3 2023 to correct $1.6M understatement of Treat segment impairment.","XpresSpa revenue grew 39% YoY to $19.5M; plans for Penn Station location and Naples Wax Center expansion to ~10 locations by early 2025.","CDC biosurveillance program expanded to $36.7M funding; new collection sites at MIA and ORD.","Cash and marketable securities totaled $23.0M at Dec 31, 2023; no long-term debt."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.6,"consensus_revenue_estimate":null,"consensus_revenue_actual":8726000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222940,"accession_number":"0001104659-24-046836","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-04-12T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"XWELL restates Q3 2023 financials on impairment accounting error; $1.6M understatement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee found GAAP misapplication in Treat segment impairment for Q3 2023.","Preliminary estimate: impairment expenses understated by $1,613,000 in Q3 2023.","Previously reported Q3 2023 impairment of ~$6.8M; restated financials will be in 2023 Form 10-K.","No impact on cash, cash equivalents, or marketable securities balances.","Management expects at least one material weakness in internal controls related to the restatement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222939,"accession_number":"0001104659-24-041895","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"XWELL files for 15-day extension on 2023 Form 10-K; audit not yet complete","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Files Form 12b-25 with SEC for late 2023 annual report; 15 calendar day extension sought.","Delay attributed to need for more supporting documentation and audit completion by independent auditors.","Company anticipates filing Form 10-K as soon as practicable after extension period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242427,"accession_number":"0001104659-24-033244","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"XWELL expands CDC biosurveillance contract to $36.7M, adds Miami and Chicago airports","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CDC contract value expanded from ~$15.9M (Aug 2023) to estimated $36.7M+ in March 2024 extension.","Two new airport locations added: Miami (MIA) and Chicago (ORD), bringing total to nine active sites.","Expansion includes multi-pathogen testing for >30 pathogens, with samples including nasal swabs and wastewater.","XWELL's XpresCheck operates mobile testing centers; program serves as early detection for novel pathogens."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242426,"accession_number":"0001104659-24-009767","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K/A","filed_at":"2024-02-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"XWELL adds director Wizenberg to Audit and Compensation committees","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Gaëlle S. Wizenberg elected to board effective Jan 1, 2024, previously reported.","On Jan 30, 2024, appointed to Audit Committee and Compensation Committee.","This amendment updates prior 8-K to reflect committee assignments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259819,"accession_number":"0001104659-23-126410","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-12-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"XWELL appoints Gaëlle Wizenberg to Board; Director Donald Stout retires after 11 years","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Donald Stout resigns as director and committee member effective Jan 1, 2024; no disagreement with management.","Gaëlle Wizenberg appointed independent director effective Jan 1, 2024, to fill the vacancy.","Wizenberg founded Charlie Banana (sold to P&G) and has 25+ years in consumer/retail/wellness.","She will stand for election at the 2024 annual meeting; committee assignments not yet determined.","Compensation will follow the company's standard non-employee director program; indemnification agreement expected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259818,"accession_number":"0001104659-23-118179","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q3 revenue $7.5M; airport spa revenue up 39% YoY; non-cash impairment $6.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $7.5M, down from $10.7M in Q3 2022; XpresSpa revenue grew ~39% YoY to $5.0M.","Non-cash goodwill & intangible impairment of $6.8M, primarily on HyperPointe and Treat assets.","GAAP loss from operations $10.5M; non-GAAP loss (excl. impairment) $3.7M vs. $7.1M loss in Q3 2022.","Naples Wax Center acquired for ~$1.5M in mid-September; plan to grow by 8–10 locations in 12-18 months.","CDC renewed TGS contract for ~$16M; expanded to test for 30+ priority pathogens at four U.S. airports."],"consensus_eps_estimate":-0.816,"consensus_eps_actual":-5.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":22706000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259817,"accession_number":"0001104659-23-108807","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-10-12T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"XWELL regains Nasdaq minimum bid price compliance; delisting risk removed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on Oct 12, 2023, confirming compliance with Bid Price Rule.","Closing bid price was at least $1.00 for 10 consecutive days from Sep 28 to Oct 11, 2023.","Previously disclosed non-compliance in Oct 2022; deficiency notice now closed.","Common stock (XWEL) continues listing on The Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259816,"accession_number":"0001104659-23-106417","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"XWELL CEO Scott Milford to present at Water Tower Research fireside chat on Oct 4","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO Scott Milford to participate in investor fireside chat hosted by Water Tower Research on October 4, 2023 at 2:30 p.m. ET.","Presentation to cover out-of-airport strategy and recent acquisition of Naples Wax Center.","Milford will also update on profitability plan including cost reduction and operational improvement initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277073,"accession_number":"0001104659-23-104093","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-09-27T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"XWELL enacts 1-for-20 reverse stock split effective Sept 27 to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split reduces outstanding shares from approx 83.5M to 4.17M; effective 5pm ET Sept 27.","Trading on split-adjusted basis begins Sept 28; symbol XWEL unchanged; new CUSIP 98420U 802.","Split aims to raise per-share price to meet Nasdaq $1 minimum bid price requirement.","No fractional shares issued; cash in lieu of fractional shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277072,"accession_number":"0001104659-23-100040","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-09-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"XWELL acquires Naples Wax Center for $1.5M, expands outside airport","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of Naples Wax Center, a group of 3 upscale waxing boutiques in Florida, for ~$1.5 million.","Plans to add 8-10 new locations over the next 12-18 months using geographic synergies and lower off-airport costs.","Brandon Stewart, co-founder of Naples Wax, appointed Director of Development to lead off-airport retail expansion.","Customers gain access to XWELL Rewards Program and cross-service promotions across family of brands.","Transaction marks first step in building a retail portfolio outside airports, targeting revenue growth and profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277071,"accession_number":"0001104659-23-095322","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-08-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"XWELL shareholders approve reverse stock split, reject advisory say-on-pay at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at ratio 1:8 to 1:20 approved (27.8M for, 17.1M against; 66.2% of votes cast).","Advisory vote on named executive officer compensation not approved (3.9M for, 17.2M against; 81.6% against).","Directors Milford, Weinstein, Bernstein, Stout, Lebowitz reelected despite high withhold votes (e.g., Bernstein 5.3M for, 16.6M withheld).","Marcum LLP ratified as auditor for FY2023 (31.6M for, 10.6M against); adjournment proposal failed (17.9M for, 25.7M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277070,"accession_number":"0001104659-23-091433","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"XWELL Q2 2023 revenue down 40% YoY; net loss improves to $5.7M; CDC renews $15.9M biosurveillance contract","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $8.2M vs $13.6M in Q2 2022; XpresSpa revenue up 59% YoY.","Net loss attributable to common shareholders $5.7M, improved from $7.9M loss.","CDC renews biosurveillance program with contract value ~$15.9M; all XpresCheck locations closed.","Appointed Suzanne Scrabis as CFO effective July 10, 2023.","Cash and marketable securities $31.9M; no long-term debt."],"consensus_eps_estimate":-1.428,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":15238000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294972,"accession_number":"0001104659-23-075565","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"XWELL appoints Suzanne A. Scrabis as CFO effective July 10, 2023; details compensation","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Suzanne A. Scrabis named CFO, starting July 10, 2023; Omar Haynes returns to VP Treasury & Finance role.","Annual base salary $300,000; short-term incentive target 50% of base salary, half guaranteed for 2023.","Initial equity awards: 75,000 NQSOs and 100,000 RSUs vesting quarterly over one year; eligible for LTIP up to 1.75x salary.","Severance: 50% of base salary paid over 6 months if terminated without cause or for good reason, subject to release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294971,"accession_number":"0001104659-23-072254","cik":1410428,"company_name":"XWELL, Inc.","ticker":"XWEL","form_type":"8-K","filed_at":"2023-06-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"XWELL CFO hire does not proceed; interim CFO continues with RSU grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Valerie Lightfoot's employment as CFO did not commence as planned on June 12, 2023.","Company decided to move in a different direction for permanent CFO search.","Omar A. Haynes continues as Interim CFO and principal financial/accounting officer.","Haynes receives one-time grant of 100,000 RSUs vesting quarterly over one year.","RSU vesting starts Q3 2023, fully vested by June 30, 2024, subject to continuous service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11570000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-06-16T23:59:59+00:00|294971"}